Brainlab Elements - Trajectory Planning 2.6Recalls & reported problems
Brainlab SE · Class 2
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 04056481142674), received between Jul 3, 2026 and Jul 3, 2026 — classified as 2 injuries.
The most frequently reported specific device problem is “Use of Device Problem” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Use of Device Problem2
Patient problems
- No Clinical Signs, Symptoms or Conditions2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryJul 3, 2026Use of Device Problem
A CRANIAL SURGERY FOR TWO DEPTH ELECTRODE PLACEMENTS IN THE BRAIN, TO THE SUBSTANTIA NIGRA WITH DEPTHS OF CA. 72MM FROM THE LEFT AND CA. 77MM FROM THE RIGHT, TO TREAT PARKINSON'S DISEASE WITH DEEP BRAIN STIMULATION (DBS), HAS BEEN PLANNED WITH THE BRAINLAB ELEMENTS - TRAJECTORY PLANNING 2.6 FOR THE ELECTRODE POSITIONS, TO PLACE THEM WITH A NON-BRAINLAB STEREOTACTIC ARC/FRAME. FROM EVALUATING THE PLACED ELECTRODES WITH AN INTRA-OPERATIVE CT SCAN DURING THE SURGERY, THE SURGEON DETERMINED THAT BOTH ELECTRODES WERE PLACED IN A PATH DEVIATING SHIFTED CA. 3.5MM FROM THE PLANNED/INTENDED TRAJECTORY. THE SURGEON ALSO EVALUATED AND DETERMINED THAT THE POSITIONS OF THE ELECTRODES ARE STILL SUITABLE FOR SUCCESSFUL TREATMENT, WITHOUT ANY CHANGES, AT THE SAME SURGERY. ACCORDING TO THE SURGEON (TREATING CLINICIAN): THE OUTCOME OF THE SURGERY WAS SUCCESSFUL AS INTENDED, WITH NO CHANGES TO THE PLANNED PROCEDURE. THERE WAS NO DIRECT (OR INCREASED) RISK TO HARM A CRITICAL STRUCTURE DUE TO THE DEVIATING PLACEMENTS. THERE WAS NO HARM OR NEGATIVE EFFECT TO THE PATIENT DUE TO THE DEVIATING PLACEMENTS, ALSO NOT DUE TO THE SURGERY/ANESTHESIA PROLONGATION (FOR EVALUATION) OF CA. 20MIN. THERE WERE NO REMED
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25703690 ↗InjuryJul 3, 2026Use of Device Problem
A CRANIAL SURGERY FOR TWO DEPTH ELECTRODE PLACEMENTS IN THE BRAIN, TO THE SUBSTANTIA NIGRA WITH DEPTHS OF CA. 79MM FROM THE LEFT AND CA. 82MM FROM THE RIGHT, TO TREAT PARKINSON'S DISEASE WITH DEEP BRAIN STIMULATION (DBS), HAS BEEN PLANNED WITH THE BRAINLAB ELEMENTS - TRAJECTORY PLANNING 2.6 FOR THE ELECTRODE POSITIONS, TO PLACE THEM WITH A NON-BRAINLAB STEREOTACTIC ARC/FRAME. FROM EVALUATING THE PLACED ELECTRODES WITH AN INTRA-OPERATIVE CT SCAN DURING THE SURGERY, THE SURGEON DETERMINED THAT BOTH ELECTRODES WERE PLACED IN A PATH DEVIATING SHIFTED CA. 4MM FROM THE PLANNED/INTENDED TRAJECTORY. THE SURGEON DECIDED TO PLACE THE ELECTRODES IN A CORRECTED POSITION, USING THE EXISTING BURR HOLES, SUCCESSFULLY AT THE SAME SURGERY WITH NO FURTHER CHANGES TO THE EXISTING SURGICAL INVASIVE ACTIONS. ACCORDING TO THE SURGEON (TREATING CLINICIAN): THE OUTCOME OF THE SURGERY WAS SUCCESSFUL AS INTENDED, WITH THE ELECTRODES IN CORRECT POSITIONS. THERE WAS NO DIRECT (OR INCREASED) RISK TO HARM A CRITICAL STRUCTURE DUE TO THE DEVIATING PLACEMENTS. THERE WAS NO HARM OR NEGATIVE EFFECT TO THE PATIENT DUE TO THE DEVIATING PLACEMENTS, ALSO NOT DUE TO THE SURGERY/ANESTHESIA PROLONGATION OF CA. 45MIN. THER
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25703103 ↗
Other Neurological Stereotaxic Instrument devices
- StealthStation S8 Platform 9735665Medtronic Navigation, Inc. · Neurological stereotaxic Instrument4 deaths4,668 reports
- Stealthstation® S7™ 9733856Medtronic Navigation, Inc. · Neurological stereotaxic Instrument6 deaths3,908 reports
- StealthStation S8 Platform 9735665Medtronic Navigation, Inc. · Neurological stereotaxic Instrument1 death1,896 reports
- StealthStation S8 9735669Medtronic Navigation, Inc. · Neurological stereotaxic Instrument1,831 reports
- StealthStation S8 Platform 9735665Medtronic Navigation, Inc. · Neurological stereotaxic Instrument2 deaths1,542 reports
- Fusion™ ENT Image Guidance System 9733560XOMMedtronic Navigation, Inc. · Neurological stereotaxic Instrument1,316 reports
- Stealthstation® S7™ 9733858Medtronic Navigation, Inc. · Neurological stereotaxic Instrument8 deaths984 reports
- Stealthstation® S7™ 9733858Medtronic Navigation, Inc. · Neurological stereotaxic Instrument1 death695 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page